sglt vs glp 1 GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes Metabolic and cardiovascular benefits with

Combining it with corticosteroids could aid recovery after treatment

This was evidenced by increased CYP1A1, interleukin-10 (IL-10), and IL-22 levels that consequently alleviate metabolic syndrome and inflammation

While genetic testing does not predict your exact medication response, it can support a more personalized understanding of why your provider might recommend specific dosing approaches or intervals tailored to your biology

Understanding these separate mechanisms is essential when considering whether the two could be used together, as their pharmacological profiles do not directly overlap, but their downstream metabolic effects may interact in clinically meaningful ways

95% CI, 0.48 to 0.70) (Fig